Effective and safe treatment of psychotic depression in an elderly patient with quetiapine and ECT

Öz

Major depression with psychotic features (MDP) is the state that major depression is accompanied by delusions and halucinations. Electroconvulsive therapy (ECT) is an important option used in the treatment. Combination of antidepressants and antipsychotics is also adviced as another treatment option. Lack of data about the treatment of MDP with the combination of ECT and an atypical antipsychotic quetiapine is noteworthy to mention. Here, we aimed to report successful and safe treatment of an elderly patient with MDP by the combination of ECT and quetiapine.

Anahtar Kelimeler

• -

Yaşlı bir hastada ketiyapin ve EKT ile psikotik özellikli depresyonun etkili ve güvenli tedavisi

Öz

Psikotik özellikli major depresyon (PÖMD), depresyona sanrı ve varsanı eşlik etmesi durumudur. Elektrokonvulsif tedavi (EKT) tedavide kullanılan önemli bir seçenektir. Bir başka tedavi seçeneği olarak antidepresanlar ile birlikte antipsikotiklerin kullanılması önerilmektedir. PÖMD hastalarında EKT ve bir atipik antipsikotik olan ketiyapin ile tedavi konusunda literatürde bilgi olmaması dikkat çekicidir. Bu yazıda PÖMD tanısı alan yaşlı bir hastada EKT beraberinde ketiyapinin güvenli ve etkili bir şekilde kullanıldığını bildirmeyi amaçladık.

Anahtar Kelimeler

• Psikotik özellikli major depresyon, elektrokonvulsif tedavi, ketiyapin

Kaynakça

1. Schatzberg AF, Rothschild AJ. Psychotic (delusional) major depression: Should it be included as a distinct syndrome in DSMIV. Am J Psychiatry.1992;149:733-745.
2. Rothschild AJ. Challenges in the treatment of depression with psychotic features. Biol Psychiatry. 2003;15:680-690.
3. Johnson J, Horwath E, Weissman MM. The validity of major depression with psychotic features based on a community study. Arch Gen Psychiatry. 1991;48:1075-81.
4. American Psychiatric Association. Practice guideline for the treatment of major depressive disorder (revision). Am J Psychiatry. Suppl 2000;157:(suppl. 4).
5. Pande A, Grunhaus L, Hasket R, Haskett R, Greden JF. Electroconvulsive therapy in delusional and nondelusional depressive disorder. J Affect Disord. 1990;19: 215–219.
6. Parker G, Hadzi-Pavlovic D, Hickie I, Boyce P, Mitchell P, Wilhelm K, Brodarty H. Distinguishing psychotic and non-psychotic melancholia. J Affect Disord. 1991;22:135-148.
7. Gazdag G, Barna I, Ivanyi Z, Tolna J. The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy. Ideggyogy Sz. 2004;57:385-390.
8. Masdrakis VG, Florakis A, Tzanoulinos G, Markatou M, Oulis P. Safety of the electroconvulsive therapy-ziprasidone combination. J ECT. 2010;26:139-142.

9. Alexopoulos GS. Mood disorders. Comprehensive Textbook of Psychiatry, BJ Saddock, VA Saddock (editors). Philadelphia, Lippincott Williams and Wilkins, 2000:3060-3067.
10. Bellingham GA, Peng PW. Duloxetine: a review of its pharmacology and use in chronic pain management. Reg Anesth Pain Med. 2010;35:294-303.
11. Chen J, Gao K, Kemp DE. Second-generation antipsychotics in major depressive disorder: update and clinical perspective. Curr Opin Psychiatry. 2011;24:10-17.
12. Ravindran AV, Al-Subaie A, Abraham G. Quetiapine: novel uses in the treatment of depressive and anxiety disorders. Expert Opin Investig Drugs. 2010;19:1187-1204.
13. Dell’osso B, Palazzo MC, Oldani L, Altamura AC. The Noradrenergic Action in Antidepressant Treatments: Pharmacological and Clinical Aspects. CNS Neurosci Ther. 2010;14:1-10.
14. Zarate CA Jr, Rothschild AJ, Fletcher KE, Madrid A, Zapatel J. Clinical predictors of acute response with quetiapine in psychotic mood disorders. J Clin Psychiatry. 2000;61:185-189.
15. Tang WK, Ungvari GS. Efficacy of electroconvulsive therapy combined with antipsychotic medication in treatment-resistant schizophrenia: a prospective, open trial. J ECT. 2002;18:90-94
16. Nothdurfter C, Eser D, Schüle C, Zwanzger P, Marcuse A, Noack I, Möller HJ, Rupprecht R, Baghai TC. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry. 2006;7:162-170.
17. Tan QR, Wang W, Wang HH, Zhang RG, Guo L, Zhang YH. Treatment of catatonic stupor with combination of modified electroconvulsive treatment and olanzapine: a case report. Clin Neuropharmacol. 2006;29:154-156.